Starling Oncology STLN
NASDAQ STLN
$5.97 -0.12 (-1.97%)
At close: Sep 3, 2026 · 4:00 PM EDT

Starling Oncology (STLN) Non-Current Deferred Tax Liability (2020 - 2025)

Analysis

Starling Oncology (STLN) Non-Current Deferred Tax Liability (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 90.36 Bn 89.35 Bn 15.19 Bn
2 Tenet Healthcare 22.02 Bn 19.85 Bn 4.45 Bn
3 Encompass Health 12.13 Bn 11.99 Bn 1.34 Bn
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn
5 Universal Health Services 10.09 Bn 9.95 Bn 3.29 Bn
6 Ensign 9.97 Bn 9.65 Bn 306.24 Mn
7 Chemed 6.93 Bn 6.89 Bn 221.47 Mn
8 Pacs 6.81 Bn 6.64 Bn 338.46 Mn
9 Concentra Group Holdings Parent 4.32 Bn 4.16 Bn 192.10 Mn
10 Starling Oncology 609.95 Mn 568.85 Mn 27.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 7.77 Mn
Mar 31, 2025 32,000.00
Dec 31, 2024 9.22 Mn
Sep 30, 2024 32,000.00
Jun 30, 2024 32,000.00
Mar 31, 2024 32,000.00
Dec 31, 2023 10.21 Mn
Sep 30, 2023 158,000.00
Jun 30, 2023 78,000.00
Mar 31, 2023 82,000.00
Dec 31, 2022 8.70 Mn
Sep 30, 2022 554,000.00
Jun 30, 2022 502,000.00
Mar 31, 2022 551,000.00
Dec 31, 2021 2.03 Mn
Dec 31, 2020 3.73 Mn